#pharmaceuticals
America Wants to Make More Generic Drugs. India Shows Why That’s Hard. - The New York Times
America Wants to Make More Generic Drugs. India Shows Why That’s Hard.The New York Times Trump’s huge tariffs on some drugmakers could end up backfiring | CNN BusinessCNN Peoria pharmacist says new drug tariffs could raise costs for imported medicationsWEEK |…
Politics, weak regulation are failing Nigeria’s health system —Ex-PSN president, Akintayo
Olumide Akintayo, a Fellow and past President of the Pharmaceutical Society of Nigeria, speaks with Sade Oguntola on the urgent need to strengthen Nigeria’s healthcare and pharmaceutical sectors, including a greater role for community pharmacists in strengthe…
Alkem Laboratories launches NeuCeno for partial-onset seizures in adults
The once-daily oral therapy is available in five strengths, with clinical studies showing reductions in seizure frequency among adults with uncontrolled focal seizures
Antibiotic sales decline, but concerns over inappropriate use remain
Pharmarack data show anti-bacterial unit sales falling since 2023; experts say lower volumes alone do not indicate more appropriate antibiotic use
Belarus ready for deep industrial cooperation and widen agri sector partnership with India: FM Maxim Ryzhenkov
Belarus is ready for deeper industrial cooperation and is highly interested in the advanced development of Indian pharmaceutical companies, and prepared to establish joint ventures and localise production in India, Maxim Ryzhenkov said.
International Conference On AI - Driven Drug Development Begins In Indore
Thyroid medication recalled throughout US — see all the products affected
The company says the reason is the medication was found to be "subpotent," that is, it may not be strong enough to work effectively.
Lupin Announces the Approval of Diazepam Injection, USP in the United States
MUMBAI, India, and NAPLES, Fla., July 28, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval under the Federal Food, Drug, and…
Government notifies Navi Mumbai Airport as a Port for Import of drugs under Drug Rules
Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
MUMBAI, India, July 7, 2026 /PRNewswire/ -- Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, released its Annual Report for FY2026, highlighting a year of strengthening its global platf…
Veterinary API Manufacturing Market to Reach USD 18.48 Billion by 2035 as Animal Health Investments and Zoonotic Disease Prevention Accelerate – SNS Insider
The U.S. Veterinary API Manufacturing Market was valued at USD 2.02 Billion in 2025 and is projected to reach USD 4.84 Billion by 2035, while Europe is expected to grow from USD 2.02 Billion to USD 4.84 Billion during the forecast period, supported by expandi…
Indians spent Rs 1 . 6 lakh crore on medicines in 2022 - 23 : NHA
US imports nearly 40 pc of generics from India because we trust India : Ambassador Sergio Gor
We import 40 % generics from India : Sergio Gor cites trust as US India ties gain momentum
Global Chemical Market to Hit USD 8.78 Trillion by 2035 Amid Rising Demand from Manufacturing, Agriculture, and Pharmaceuticals | Research by SNS Insider
U.S. Chemical Market to Reach USD 1.75 Trillion and Europe Chemical Market to Surpass USD 1.88 Trillion by 2035 as Sustainable and Specialty Chemicals Gain Momentum U.S. Chemical Market to Reach USD 1.75 Trillion and Europe Chemical Market to Surpass USD 1.88…
Foundayo and Zepbound now covered for millions of Americans
CVS Caremark begins covering Foundayo June 1 and resumes Zepbound coverage by October 1 Eligible patients may pay as low as $25 a month for their medicine INDIANAPOLIS, May 28, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an access m…
India's drug lifeline to Africa disrupted by Iran war
The fragile logistics corridor via Gulf states that connects African patients with critical Indian pharmaceuticals has been thrown into disarray with the Strait of Hormuz closed. India has often been called the "pharmacy of the Global South," and for African …
Government okays Skymap Pharmaceuticals' Rs 121-cr bid to buy IMPCL
The government has approved the sale of Indian Medicines Pharmaceutical Corporation Ltd. Skymap Pharmaceuticals Pvt Ltd will acquire the company for over Rs 121 crore. This strategic sale involves 100 percent stake and management control. IMPCL manufactures A…
Inside the Irish factory at the centre of the global weight-loss revolution
Eli Lilly’s huge 50-hectare manufacturing hub in Kinsale has placed Ireland at the centre of the biggest shift in global medicine in decades
Generic Ozempic is now on Canadian shelves. Is it the same as the brand name version?
Some Canadian pharmacists are already stocking their shelves with generic versions of semaglutide, more commonly known by the brand name Ozempic. But will these generics be just as good, and how much will the cost come down?
Sourav K. Mishra, M.D. / All India Institute of Medical Sciences - 724881 - 04/29/2026
In Vivo Bioavailability-Bioequivalence Studies – Clinical
AbbVie loses patent plea for Hep C drug
The Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to affordable treatment for millions. The patent office refused the application after AbbVie failed to contest oppositions and…
Bio-Thera Solutions' Golimumab Biosimilars Receive FDA Approval as First Biosimilars to Simponi® and Simponi Aria®; Accord BioPharma to Commercialize IMMGOLIS™ (golimumab-sldi) and IMMGOLIS INTRI™ (golimumab-sldi) in the United States
GUANGZHOU, China, May 18, 2026 /PRNewswire/ -- Bio-Thera Solutions (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, and Accord BioPharma, Inc, the U.S. specialty division of Intas Pharmac…
Weight-loss drug semaglutide set to get cheaper as generic wave builds in India
Prices for generic semaglutide, a popular weight-loss drug, are expected to fall by more than half in the coming months. This sharp decline is anticipated with the entry of smaller brands and a significant drop in raw material costs. The cost for a month's do…
When will cheaper generic Ozempic arrive? #health
Timeline for generic Ozempic in the U.S. Cheaper generic versions of Ozempic are moving through other markets first, but the United States timeline is still unclear based on the coverage provided. One report states that India already has a generic version , a…
Cheaper generic Ozempic is coming soon — but not for Americans
India got it earlier this year, and Canada approved it last month. But when is the United States going to get a generic version of Ozempic?
India-Japan seek to advance coop in critical minerals, semiconductors & ICT
India and Japan have strengthened economic ties. A key dialogue focused on industrial and technological cooperation. Five sectors were prioritised: critical minerals, semiconductors, ICT, clean energy, and pharmaceuticals. Both nations aim to build resilient …
Dr. Reddy’s to Launch Generic Ozempic in Canada Within Days
Dr Reddy’s Laboratories Ltd. plans to launch its version of generic Ozempic this month, filling a void in the Canadian market months after a key patent expiry and paving the way for cheaper access to the GLP-1 drugs.
Drugmakers must report safety data from launch date, not approval date: CDSCO
India's drug regulator has issued a new directive for pharmaceutical companies. Periodic Safety Update Reports for new drugs must now be submitted from the actual market launch date. This change aims to strengthen patient safety monitoring. Previously, report…